@article { ISI:000345654000087,
	title = {From micron to nano-curcumin by sophorolipid co-processing: highly enhanced bioavailability, fluorescence, and anti-cancer efficacy},
	journal = {RSC Advances},
	volume = {4},
	number = {104},
	year = {2014},
	month = {NOV},
	pages = {60334-60341},
	publisher = {ROYAL SOC CHEMISTRY},
	address = {THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND},
	abstract = {<p>Co-sonication of curcumin and acidic sophorolipid in aqueous solution is shown to lead to a dramatic enhancement of curcumin bioavailability through size reduction and encapsulation. The interaction between the two is studied and discussed based on optical absorption, photoluminescence, dynamic light scattering (DLS), zeta potential, FE-SEM, TEM, Infrared spectroscopy and X-ray diffraction measurements. The cytotoxicity effects of curcumin on breast cancer cell lines, MCF-7 and MDA-MB-231, are shown to be significantly enhanced by the formation of its complex with sophorolipid. The relative cytotoxicity of curcumin with its SL(A) complex is more due to the presence of the glucose moiety. The results further suggest that sophorolipid based formulations, which solubilize and nano-encapsulate curcumin after lipid digestion, show great potential for curcumin cell entry.</p>},
	issn = {2046-2069},
	doi = {10.1039/c4ra07300b},
	author = {Singh, Pradeep Kumar and Wani, Kirtee and Kaul-Ghanekar, Ruchika and Prabhune, Asmita and Ogale, Satishchandra}
}
@article { ISI:000350222400077,
	title = {From micron to nano-curcumin by sophorolipid co-processing: highly enhanced bioavailability, fluorescence, and anti-cancer efficacy (vol 4, pg 60334, 2014)},
	journal = {RSC Advances},
	volume = {5},
	number = {28},
	year = {2015},
	month = {FEB},
	pages = {22075},
	publisher = {ROYAL SOC CHEMISTRY},
	address = {THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND},
	issn = {2046-2069},
	doi = {10.1039/c5ra90018b},
	author = {Singh, Pradeep Kumar and Wani, Kirtee and Kaul-Ghanekar, Ruchika and Prabhune, Asmita and Ogale, Satishchandra}
}
@article {43436,
	title = {Evaluating the anticancer activity and nanoparticulate nature of homeopathic preparations of Terminalia chebula},
	journal = {Homeopathy},
	volume = {105},
	year = {2016},
	month = {NOV},
	pages = {318-326},
	abstract = {Background: Breast cancer is the most common cancer diagnosed among women and is the second leading cause of cancer death. Homeopathic medicines are part of the alternative medicines that are given as a supportive therapy in breast cancer. The objective of this study was to investigate the anticancer activity of commercially available homeopathic preparations of Terminalia chebula (TC) and evaluate their nanoparticulate nature. 
Methods: Mother tincture (MT) and other homeopathic preparations (3X, 6C and 30C) of TC were tested for their effect on the viability of breast cancer (MDAMB231 and MCF7) and non-cancerous (HEK 293) cell lines by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell growth assay was performed to analyze the effect of the different potencies on the growth kinetics of breast cancer cells. MT and 6C were evaluated for the presence of nanoparticles by using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). 
Results: MT decreased the viability of breast cancer (MDAMB231 and MCF7) and non-cancerous (HEK 293) cells. However, the other potencies (3X, 6C and 30C) decreased the viability of only breast cancer cells without affecting the viability of the non-cancerous cells. All the potencies, MT, 3X, 6C and 30C, reduced growth kinetics of breast cancer cells, more specifically at 1:10 dilution at 24, 48 and 72 h. Under SEM, MT appeared as a mesh-like structure whereas under TEM, it showed presence of nanoclusters. On the other hand, 6C potency contained 20 nm sized nanoparticles. 
Conclusion: The current study reports the anticancer activity of homeopathic preparations of TC against breast cancer and reveals their nanoparticulate nature. These preliminary results warrant further mechanistic studies at both in vitro and in vivo levels to evaluate the potential of TC as nanomedicine in breast cancer.},
	doi = {10.1016/j.homp.2016.02.004},
	author = {Wani, Kirtee and Shah, Nilesh and Prabhune, Asmita and Jadhav, Arun and Ranjekar, Prabhakar and Kaul-Ghanekar, Ruchika}
}
